Ketorolac Tromethamine Injection, Solution
Product Images NDC 65145-147

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 65145-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ketorolac-spl-15mg-carton (Ketorolac Spl 15mg Carton)

Ketorolac-spl-15mg-carton (Ketorolac Spl 15mg Carton)
This text contains a description of a product which appears to be a medication. It includes information about the size of the product, the details to be printed during packing, and the manufacturer's details. It also indicates the dosage, storage conditions, and how to administer the medication. The text provides instructions for dispensing the enclosed Medication Guide to each patient. Additionally, there is a warning to protect the product from light and a recommendation of retaining it in the carton until the time of use.*
FDA Label Image

15mg-vial (Ketorolac Spl 15mg Vial)

15mg-vial (Ketorolac Spl 15mg Vial)
NDC 65145-146-01 is a single-dose vial of Ketorolac Tromethamine injection manufactured by Caplin Steriles Limited in India. It contains 15 mg/mL of the medication and is meant for intravenous or intramuscular use. This product is only available by prescription.*
FDA Label Image

Ketorolac-spl-30mg-carton (Ketorolac Spl 30mg Carton)

Ketorolac-spl-30mg-carton (Ketorolac Spl 30mg Carton)
This appears to be a label or packaging information for an injection containing Ketorolac Tromethamine. Each mL of the injection contains 30mg of the ingredient and other components like alcohol, sodium chloride, sterile water, and hydrochloric acid. The label also provides important details such as product code, storage temperature, and method of administration (intravenous or intramuscular) along with a caution to protect it from light. There is a mention of a medication guide that needs to be dispensed to each patient. The first part of the text seems to indicate a blank unvarnished area to be used for online printing of 2D code, Sr. No., GTIN, Lot number, and Exp details during batch overprinting.*
FDA Label Image

30mg-vial (Ketorolac Spl 30mg Vial)

FDA Label Image

Ketrolac-spl-structure (Ketorolac Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.